Get the Stockscreener App
15.82
1.80%
-0.29
Pre-market:
14.25
-1.57
-9.92%
Cargo Therapeutics Inc stock is traded at $15.82, with a volume of 209.56K.
It is down -1.80% in the last 24 hours and down -28.80% over the past month.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.
See More
Previous Close:
$16.11
Open:
$16.1
24h Volume:
209.56K
Relative Volume:
0.72
Market Cap:
$740.13M
Revenue:
-
Net Income/Loss:
$-147.71M
P/E Ratio:
-
EPS:
-
Net Cash Flow:
$-127.89M
1W Performance:
-16.87%
1M Performance:
-28.80%
6M Performance:
-22.49%
1Y Performance:
+7.99%
1-Day Range:
$15.27
$16.68
1-Week Range:
$15.27
$20.13
52-Week Range:
$13.56
$33.92
Cargo Therapeutics Inc Stock (CRGX) Company Profile
Name
Cargo Therapeutics Inc
Sector
Industry
Phone
650-499-8950
Address
835 INDUSTRIAL ROAD, SUITE 400, SAN CARLOS
Compare CRGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| CRGX | 15.82 | 740.13M | 0 | -147.71M | -127.89M | 0.00 |
| VRTX | 451.23 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 743.35 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 591.82 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 248.79 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 102.14 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Cargo Therapeutics Inc Stock (CRGX) Latest News
Long Term Trading Analysis for (CRGX) - Stock Traders Daily
CARGO Therapeutics (NASDAQ:CRGX) Earns Buy Rating from HC Wainwright - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Earns Buy Rating from Chardan Capital - Defense World
Janus Henderson Group PLC's Strategic Acquisition in Cargo Thera - GuruFocus.com
RTW INVESTMENTS, LP Expands Stake in Cargo Therapeutics Inc - GuruFocus.com
CARGO Therapeutics Advances in Cancer Therapy Development - TipRanks
CARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
Reviewing CARGO Therapeutics (CRGX) & The Competition - Defense World
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Receives Average Rating of “Buy” from Analysts - Defense World
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Receives Average Rating of "Buy" from Brokerages - MarketBeat
Critical Comparison: CARGO Therapeutics (CRGX) and Its Rivals - Defense World
How to Take Advantage of moves in (CRGX) - Stock Traders Daily
CARGO Therapeutics (CRGX) & The Competition Financial Survey - Defense World
CARGO Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire
CARGO Therapeutics Announces ASH 2024 Abstract on CRG-023, - GlobeNewswire
CARGO Therapeutics CEO to Present at Major Healthcare Investor Conferences | CRGX Stock News - StockTitan
Apple Inc (AAPL-Q) QuotePress Release - The Globe and Mail
TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail
Dow Jones Industrials Average (DOWI) QuotePress Release - The Globe and Mail
TSX Preferred Share Index (TXPR) QuotePress Release - The Globe and Mail
S&P 500 Energy [Sector] (SREN) QuotePress Release - The Globe and Mail
TSX Global Gold EW Index (TXGE) QuotePress Release - The Globe and Mail
Microsoft Corp (MSFT-Q) QuotePress Release - The Globe and Mail
Nasdaq US MD Cap Telecom Index USD (NQTI) QuotePress Release - The Globe and Mail
CARGO Therapeutics Announces ASH 2024 Abstract on CRG-023, a Tri-specific CAR T, Highlighting Innovative Construct Design and Durable Anti-B-Cell Lymphoma Activity - StockTitan
US Midwest Busheling (THN25) Quote - The Globe and Mail
Alphabet Cl A (GOOGL-Q) QuotePress Release - The Globe and Mail
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Short Interest Up 7.1% in October - MarketBeat
Twilio (TWLO-N) QuotePress Release - The Globe and Mail
S&P 100 Index (OEX) QuotePress Release - The Globe and Mail
Where are the Opportunities in (CRGX) - Stock Traders Daily
Reviewing CARGO Therapeutics (CRGX) & Its Rivals - Defense World
Nvelop Therapeutics to Present at the European Society of Gene & Cell Therapy (ESGCT) 31st Annual Conference - Business Wire
Creative Planning Has $19.65 Million Stake in Global X U.S. Preferred ETF (NYSEARCA:PFFD) - Defense World
CARGO Therapeutics (NASDAQ:CRGX) Trading Down 5.9%Here's What Happened - MarketBeat
Becker Logistics study exposes cargo theft risk tied to lax security - Yahoo Finance
Seelos Therapeutics (NASDAQ:SEEL) and Zoetis (NYSE:ZTS) Head-To-Head Contrast - Defense World
Here's Why We're Not Too Worried About CARGO Therapeutics' (NASDAQ:CRGX) Cash Burn Situation - Yahoo Finance
(CRGX) Long Term Investment Analysis - Stock Traders Daily
Emirates Boosts Cargo Fleet with New Boeing 777F Order as Freight Demand Surges - Yahoo Finance
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Given Average Rating of "Buy" by Brokerages - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) versus Opthea (NASDAQ:OPT) Head-To-Head Contrast - Defense World
Short Interest in CARGO Therapeutics, Inc. (NASDAQ:CRGX) Rises By 21.6% - MarketBeat
Russian Missile Hits Fourth Cargo Ship in Ukraine This Month - Yahoo Finance
Reviewing CARGO Therapeutics (NASDAQ:CRGX) & Opthea (NASDAQ:OPT) - Defense World
CARGO Therapeutics (NASDAQ:CRGX) Stock Price Up 6.2%Should You Buy? - MarketBeat
The Manufacturers Life Insurance Company Purchases 26,808 Shares of CARGO Therapeutics, Inc. (NASDAQ:CRGX) - MarketBeat
Airlines halt Florida cargo operations as Milton approaches - Yahoo Finance
(CRGX) On The My Stocks Page - Stock Traders Daily
US port strike ends, leaving cargo backlog - Yahoo Finance
TSX 60 Index (TXSX) QuotePress Release - The Globe and Mail
Cargo Therapeutics Inc Stock (CRGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.69%
6.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):